ArticlePharmacology research & perspectives2017

Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease.

Daniel S Whittaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.